[go: up one dir, main page]

CY1115081T1 - Νεο εκχυλισμα απο γαϊδουραγκαθο, μεθοδος για την παρασκευη και η χρηση του - Google Patents

Νεο εκχυλισμα απο γαϊδουραγκαθο, μεθοδος για την παρασκευη και η χρηση του

Info

Publication number
CY1115081T1
CY1115081T1 CY20131101145T CY131101145T CY1115081T1 CY 1115081 T1 CY1115081 T1 CY 1115081T1 CY 20131101145 T CY20131101145 T CY 20131101145T CY 131101145 T CY131101145 T CY 131101145T CY 1115081 T1 CY1115081 T1 CY 1115081T1
Authority
CY
Cyprus
Prior art keywords
preparation
gaidouragatho
new extract
extract
new
Prior art date
Application number
CY20131101145T
Other languages
English (en)
Inventor
Astrid Nagell
Jaime Xiol Aguirre
Santiago Rull Prous
Original Assignee
Euromed Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Euromed Sa filed Critical Euromed Sa
Publication of CY1115081T1 publication Critical patent/CY1115081T1/el

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A61P39/02—Antidotes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
    • A61K2236/30—Extraction of the material

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Botany (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Medical Informatics (AREA)
  • Biotechnology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Virology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Toxicology (AREA)
  • Molecular Biology (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Η παρούσα εφεύρεση αναφέρεται σε μια μέθοδο για την παρασκευή ενός εκχυλίσματος γαϊδουράγκαθου, ειδικότερα ενός παρασκευάσματος φλαβονολιγνάνης που έχει ένα αυξημένο ποσοστό έκλυσης και βελτιωμένη απορροφησιμότητα, και στη χρήση αυτού, ειδικότερα για τη θεραπεία και πρόληψη ηπατικών ασθενειών.
CY20131101145T 2007-12-23 2013-12-13 Νεο εκχυλισμα απο γαϊδουραγκαθο, μεθοδος για την παρασκευη και η χρηση του CY1115081T1 (el)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE102007063115 2007-12-23
DE102008039271A DE102008039271A1 (de) 2007-12-23 2008-08-23 Neuer Mariendistelextrakt, Verfahren zur Herstellung und Verwendung
EP08865199.7A EP2222320B1 (de) 2007-12-23 2008-12-23 Neuer mariendistelextrakt, verfahren zur herstellung und verwendung

Publications (1)

Publication Number Publication Date
CY1115081T1 true CY1115081T1 (el) 2016-12-14

Family

ID=40690102

Family Applications (1)

Application Number Title Priority Date Filing Date
CY20131101145T CY1115081T1 (el) 2007-12-23 2013-12-13 Νεο εκχυλισμα απο γαϊδουραγκαθο, μεθοδος για την παρασκευη και η χρηση του

Country Status (20)

Country Link
US (1) US20110027396A1 (el)
EP (2) EP2222320B1 (el)
JP (2) JP5442632B2 (el)
KR (2) KR101541938B1 (el)
CN (2) CN101925360A (el)
AU (1) AU2008340922B2 (el)
BR (1) BRPI0822069B8 (el)
CA (2) CA2709947C (el)
CY (1) CY1115081T1 (el)
DE (1) DE102008039271A1 (el)
DK (1) DK2222320T3 (el)
ES (1) ES2438003T3 (el)
HK (1) HK1203352A1 (el)
HR (1) HRP20131165T1 (el)
MX (1) MX2010006982A (el)
PL (1) PL2222320T3 (el)
PT (1) PT2222320E (el)
RU (1) RU2489161C2 (el)
SI (1) SI2222320T1 (el)
WO (1) WO2009080006A2 (el)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2010130460A1 (en) * 2009-05-14 2010-11-18 Euromed S.A. Amorphous silibinin for the treatment of viral hepatitis
CN102225085B (zh) * 2011-06-20 2012-09-05 黑龙江大学 一种从水飞蓟秸秆中提取水飞蓟总黄酮的方法
KR101316806B1 (ko) * 2011-08-02 2013-10-10 (주)이뮤노텍 글루타치온과 실리마린을 유효성분으로 함유하는 항산화 및 간보호용 조성물
KR101655396B1 (ko) * 2013-08-06 2016-09-08 에스케이바이오랜드 주식회사 수용성 밀크씨슬 추출물 및 이의 제조방법
JP2015113332A (ja) * 2013-12-16 2015-06-22 花王株式会社 生薬粉体
CN104744447B (zh) * 2013-12-31 2017-12-26 天士力制药集团股份有限公司 水飞蓟宾迷迭香酸酯及其制备方法和用途
CN104651037A (zh) * 2014-01-17 2015-05-27 吴长军 一种亚临界流体萃取水飞蓟籽仁中油脂和蛋白的方法
CN105622594B (zh) * 2016-03-17 2019-05-17 江苏中兴药业有限公司 一种高纯度水飞蓟素的制备方法
ES2706008B8 (es) * 2017-09-22 2021-07-12 Euromed S A Procedimiento para la preparacion de una composicion a partir del cardo mariano y composicion obtenida
KR102242002B1 (ko) 2019-02-21 2021-04-19 주식회사 노바케이메드 동충하초균사체로 고상발효된 홍삼 추출물을 유효성분으로 함유하는 지방간 질환 예방 또는 치료용 조성물
CN111518090B (zh) * 2020-05-12 2021-08-10 沈阳药科大学 黄烷黄酮衍生物及其制备方法和用途
KR102669644B1 (ko) * 2023-06-27 2024-05-27 한국자연한방 주식회사 실리마린 생체이용률이 증대된 밀크씨슬 추출물을 포함하는 지방간 개선, 예방 또는 치료용 조성물

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1767666C3 (de) 1968-06-01 1986-07-31 Dr. Madaus & Co, 5000 Koeln Pharmazeutische Zubereitung gegen Lebererkrankungen
DE1923982C3 (de) 1969-05-10 1978-07-13 Hoechst Ag, 6000 Frankfurt Flammfestmachen von Polyurethanschaumstoffen
DE2020407A1 (de) 1970-04-27 1971-11-11 Bernhard Dr Janiak Technisches Verfahren zur Isolierung von Silimarin
FR2181188A5 (en) * 1972-04-20 1973-11-30 Dott Inverni Della Beffa Polyhydroxyphenylchromones - by solvent extn of non-defatted fruit of Silybum marianum
US4061765A (en) * 1973-01-19 1977-12-06 Dr. Madaus & Co. Polyhydroxyphenylchromanone salts and therapeutic composition
DD112261A1 (el) * 1974-06-18 1975-04-05
DE2914330A1 (de) 1979-04-09 1980-10-30 Madaus & Co Dr Verfahren zur gewinnung von silymarin aus pflanzen
CH646695A5 (en) * 1980-10-06 1984-12-14 Madaus & Co Dr Method of obtaining silymarin from plants
DE3225688A1 (de) * 1982-07-09 1984-01-12 Suschnik Matthias Dr Verfahren zur gewinnung von silymarin aus silybum marianum
IT1241673B (it) 1989-10-09 1994-01-27 Istituto Biochimico Italiano Complessi di inclusione di silibinina con ciclodestrina, loro preparazione e composizioni farmaceutiche che li contengono.
DE19501266A1 (de) 1995-01-18 1996-07-25 Madaus Ag Verfahren zur Herstellung von Flavano-Lignan-Zubereitungen mit verbesserter Freisetzung und Resorbierbarkeit danach erhältliche Zubereitungen und deren Verwendung zur Herstellung von Arzneimitteln
KR0161349B1 (ko) 1995-01-20 1998-11-16 무라따 야스따까 압전 자기 조성물
RU2102999C1 (ru) * 1996-07-10 1998-01-27 Куркин Владимир Александрович Способ получения экстракта расторопши пятнистой
DE19744459A1 (de) * 1997-10-08 1999-04-15 Schwabe Willmar Gmbh & Co Flavonolignan-Zubereitungen, insbesondere Silymarin-Zubereitungen
IN192343B (el) * 2000-05-26 2004-04-10 Ranbaxy Lab Ltd
CZ292832B6 (cs) 2001-08-30 2003-12-17 Ivax Pharmaceuticals S.R.O. Způsob přípravy silymarinu se zvýšenou rozpustností
JP2003135023A (ja) * 2001-10-30 2003-05-13 Os Kogyo Kk 健康食品
US7238373B2 (en) * 2003-04-04 2007-07-03 Nutritox Llc Nutritional supplement

Also Published As

Publication number Publication date
PL2222320T3 (pl) 2014-02-28
RU2010130855A (ru) 2012-01-27
EP2222320B1 (de) 2013-09-18
JP2011507812A (ja) 2011-03-10
CA2922846A1 (en) 2009-07-02
BRPI0822069B8 (pt) 2021-05-25
MX2010006982A (es) 2010-12-06
AU2008340922A1 (en) 2009-07-02
JP2014074051A (ja) 2014-04-24
CA2709947C (en) 2016-05-17
CA2709947A1 (en) 2009-07-02
CN101925360A (zh) 2010-12-22
KR101541938B1 (ko) 2015-08-04
SI2222320T1 (sl) 2014-01-31
JP5442632B2 (ja) 2014-03-12
EP2567703A2 (de) 2013-03-13
KR20150038663A (ko) 2015-04-08
RU2489161C2 (ru) 2013-08-10
HRP20131165T1 (hr) 2014-01-03
EP2567703A3 (de) 2013-03-20
WO2009080006A3 (de) 2009-10-08
HK1203352A1 (en) 2015-10-30
WO2009080006A2 (de) 2009-07-02
AU2008340922B2 (en) 2012-07-19
BRPI0822069B1 (pt) 2019-10-08
DK2222320T3 (da) 2013-12-16
DE102008039271A1 (de) 2009-06-25
CN104189043A (zh) 2014-12-10
EP2222320A2 (de) 2010-09-01
PT2222320E (pt) 2013-12-23
ES2438003T3 (es) 2014-01-15
KR20100126272A (ko) 2010-12-01
BRPI0822069A2 (pt) 2015-06-23
US20110027396A1 (en) 2011-02-03
KR101607445B1 (ko) 2016-03-29

Similar Documents

Publication Publication Date Title
CY1115081T1 (el) Νεο εκχυλισμα απο γαϊδουραγκαθο, μεθοδος για την παρασκευη και η χρηση του
CY1124307T1 (el) Φαρμακευτικη συνθεση, μεθοδοι θεραπειας και χρησεις αυτων
CY1124144T1 (el) Συνθεσεις και μεθοδοι για θεραπεια εγκεφαλικου επεισοδιου σε ενα υποκειμενο επι ταυτοχρονης θεραπειας στατινης
CY1120807T1 (el) Συνθεσεις και μεθοδοι για την τροποποιηση της smn2 συναρμογης σε ενα υποκειμενο
CY1121742T1 (el) Αντισωματα s100a4 και θεραπευτικες χρησεις αυτων
CY1122278T1 (el) Αντι il-36r αντισωματα
CY1120079T1 (el) Υδατικη συνθεση που περιεχει βρωμεξινη
CY1112813T1 (el) 4-(4-κυανο-2-θειοαρυλ)διϋδροπυριμιδινονες και η χρηση αυτων
CY1123051T1 (el) Ταπενταδολη για προληψη και θεραπεια καταθλιψης και αγχους
CY1118125T1 (el) Αναστολεις ιβατ για τη θεραπεια ηπατικων νοσων
EA201190217A1 (ru) Замещенные 2-ацетамидо-5-арил-1,2,4-триазолоны и их применение
CY1118454T1 (el) Πρωτοτυποι αναστολεις πυρρολιου της αναγωγασης s-νιτροζογλουταθειονης ως θεραπευτικοι παραγοντες
CY1113640T1 (el) Μεθοδοι για την θεραπευτικη αγωγη ρευματοειδους αρθριτιδας
CY1116264T1 (el) Αντισωματα κατα ανθρωπινης αγγειοποιητινης 2
EA201001639A1 (ru) Композиции и способы их получения и применения
BRPI0922122A2 (pt) composições e métodos para tratamento de doença celíaca.
CY1115254T1 (el) Φαρμακευτικα διαλυματα, διαδικασιες για την παρασκευη τους και θεραπευτικες χρησεις
ES2352576T8 (es) Inhibidores de la replicación del virus de la inmunodeficiencia humana.
BRPI0909768A2 (pt) composto, composição farmacêutica, método para o tratamento ou prevenção de uma doença ou distúrbio mediados pela ativação de b3-adrenoceptor, e, uso de um composto""composto, composição farmacêutica, método para o tratamento ou orevenção de uma doença ou distúrbio mediados pela ativação de b3-adrenoceptor, e, uso de um composto
MA32934B1 (fr) Combinaisons inhibitrices hsp90
NO345046B1 (no) Oral doseringsform
CY1115381T1 (el) Διενυδρη υδροχλωρικη ναλμεφαινη
BRPI0912539A2 (pt) composto, composição farmacêutica , método para tratar uma doença, e, uso do composto.
BRPI0815057A2 (pt) Composto, composição farmacêutica, e, método para tratar infecção.
CY1116216T1 (el) Μεθοδος θεραπειας ασθενειας αποθηκευσης γλυκογονου